Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OAB

Sponsor
Prof. Dr. med. Marc Possover (Other)
Overall Status
Unknown status
CT.gov ID
NCT04160793
Collaborator
(none)
10
1
1
7
1.4

Study Details

Study Description

Brief Summary

The Genital Nerve Stimulation - GNS - consists of a two-step procedure with a preoperative non-surgical test-phase and a final surgical implantation of the neuroprothesis. In contrast to the classical technique of transcutaneous lead electrode implantation for sacral or pudendal nerve stimulation, the GNS-test-phase does not require any interventional procedure: because the genital nerves are located just few millimeter below the skin, test-stimulation can be achieved using skin surface or needle electrodes. Stimulation is achieved using a battery powered hand-held stimulator . The effect of the stimulation can be tested by the patient in their daily, home and professional environment, or at the practice under urodynamic testing, or if required other electrophysio-logical testing. After confirmation of the effectiveness of GNS, implantation of a permanent neuroprothesis can be planned. The procedure is performed either under general or spinal anesthesia or using only local anesthesia with IV-sedation as in the classical tension-free vaginal tape procedure (TVT). Because the GNS does not require two surgical procedures for both the test- and the final-implantation but rather only one for the final implantation, the presented protocol allows considerable cost reduction in comparison to the usual procedures for sacral or pudendal nerve stimulation.

Condition or Disease Intervention/Treatment Phase
  • Device: Genital Nerve Stimulation
N/A

Detailed Description

Pelvic organ dysfunctions are complex and difficult to treat. These conditions affect a substantial portion of the population, especially with increasing age. The two most frequent pelvic dysfunctions are the idio-pathic overactive bladder (IOAB) and erectile dysfunction (ED).

In pelvic dysfunctions, sacral nerve stimulation was the first technique for pelvic nerves stimulation that typically involves electrical stimulation of the nerve via a dorsal transformational technique of implantation. SNS evolved as a widely used treatment for OAB but does not completely resolve symptoms in the majority of patients. Because PNS reach more "sphincter-vesico-anal" fibers than SNM, PNS has been proposed for patients who have failed to respond to sacral neuromodulation. The good effects of PNS in neurogenic and in some non-neurogenic disorders. However, the implantation of a lead to the PN is not easily accomplished and the risk for lead migration with implantation below the pelvic floor is increased. So there is definitively a need for a more suitable alternative for selective stimulation within the pelvic cavity, a method that cannot only be reserved for experts in this field but for all gynecologists dealing with patients suffering from functional disorders of the bladder in daily clinical practice. The stimulation of the dorsal nerve of the pe-nis/clitoris - GNS - emerges as a very attractive alternative that might result in great outcomes for controlling urinary and fecal disorders.

Because part of the DNP lies superficially to the skin outside the pelvis, this nerve can be stimulated using surface electrodes attached to the overlying skin of the penis or close to the clitoris. This application is however limited, due to intolerance to required high stimulation amplitude. Surface electrodes have limitations such as difficulties in proper daily placement and issues related to hygiene as well as a lack of acceptance in some patients. Implanted electrodes are more suitable. However, implanted electrodes in the penis or near the clitoris, must endure the mechanical stress of penile erections and external pressure, carrying the risk of the cable/electrode breaking or being dislocated.

The GNS consists of a two-step procedure with a preoperative non-surgical test-phase and a final surgical implantation of the neuroprothesis. In contrast to the classical technique of transcutaneous lead electrode implantation for sacral or pudendal nerve stimulation, the GNS-test-phase does not require any interventional procedure: because the genital nerves are located just few millimeter below the skin, test-stimulation can be achieved using skin surface or needle electrodes. Stimulation is achieved using a battery powered hand-held stimulator . The effect of the stimulation can be tested by the patient in their daily, home and professional environment, or at the practice under urodynamic testing, or if required other electro-physiological testing. After confirmation of the effectiveness of GNS, implantation of a permanent neuroprothesis can be planned. The procedure is performed either under general or spinal anesthesia or using only local anesthesia with IV-sedation as in the classical tension-free vaginal tape procedure (TVT). Because the GNS does not require two surgical procedures for both the test- and the final-implantation but rather only one for the final implantation, the presented protocol allows considerable cost reduction in comparison to the usual procedures for sacral or pudendal nerve stimulation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Prospective unblinded interventional studyProspective unblinded interventional study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OAB
Anticipated Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
Jul 31, 2020
Anticipated Study Completion Date :
Aug 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Genital Nerve Stimulation

Stimulation of the DNP

Device: Genital Nerve Stimulation
Implantation the vaginal way a stimulation's electrode to the dorsal nerve of the clintoris in local anesthesia

Outcome Measures

Primary Outcome Measures

  1. Frequency of bladder voiding [6 months]

    Patient's report on frequency of micturition

Secondary Outcome Measures

  1. Safety of the GNS procedure [6 months]

    Record of all pre- and postoperative complications

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • women >18y

  • suffering form intractable iOAB

  • proved iOAB by urodynamic testing

  • non pregnant

  • good health

  • patients demanding for therapy of iOAB and willing taking part to the study

  • 6-9 months from last therapy with botulinum toxine A

Exclusion Criteria:
  • pregnancy

  • patients affected by a neurogenic condition

  • any health condition being a contraindication for the procedure

Contacts and Locations

Locations

Site City State Country Postal Code
1 Possover Zürich Switzerland 8008

Sponsors and Collaborators

  • Prof. Dr. med. Marc Possover

Investigators

  • Principal Investigator: Marc Possover, PhD, MD, PIMC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prof. Dr. med. Marc Possover, Director, Possover International Medical Center AG
ClinicalTrials.gov Identifier:
NCT04160793
Other Study ID Numbers:
  • GNS1
First Posted:
Nov 13, 2019
Last Update Posted:
Nov 13, 2019
Last Verified:
Nov 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 13, 2019